A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Clinical trial NCT02612558 · COMPLETED
Trial details
- NCT number
- NCT02612558
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.